
The Clorox Company (NYSE:CLX – Free Report) – Zacks Research cut their Q3 2027 earnings per share estimates for shares of Clorox in a report issued on Monday, November 16th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $1.53 for the quarter, down from their previous forecast of $1.56. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $5.74 per share. Zacks Research also issued estimates for Clorox’s Q4 2027 earnings at $1.60 EPS, Q1 2028 earnings at $1.29 EPS, Q2 2028 earnings at $1.34 EPS, Q3 2028 earnings at $1.74 EPS, Q4 2028 earnings at $1.65 EPS, FY2028 earnings at $6.01 EPS and Q1 2029 earnings at $1.36 EPS.
Several other equities analysts have also commented on the company. TD Cowen restated a “hold” rating on shares of Clorox in a research note on Tuesday, November 3rd. Wells Fargo & Company upped their price objective on shares of Clorox from $85.00 to $90.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 3rd. Deutsche Bank reiterated a “hold” rating and set a $95.00 target price on shares of Clorox in a report on Monday, October 19th. JPMorgan Chase & Co. increased their target price on shares of Clorox from $83.00 to $86.00 and gave the stock an “underweight” rating in a report on Tuesday, November 3rd. Finally, Morgan Stanley boosted their price target on shares of Clorox from $87.00 to $94.00 and gave the company an “equal weight” rating in a report on Wednesday, November 4th. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, Clorox has an average rating of “Reduce” and a consensus price target of $93.79.
Read Our Latest Stock Analysis on Clorox
Clorox Price Performance
CLX opened at $110.29 on Tuesday. Clorox has a 12-month low of $79.12 and a 12-month high of $128.90. The company has a current ratio of 0.65, a quick ratio of 0.39 and a debt-to-equity ratio of 32.91. The business’s fifty day simple moving average is $89.09 and its 200-day simple moving average is $99.55. The company has a market capitalization of $13.36 billion, a price-to-earnings ratio of 19.84, a PEG ratio of 3.42 and a beta of 0.59.
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.48. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The business had revenue of $1.91 billion during the quarter, compared to analyst estimates of $1.88 billion. During the same period in the previous year, the company posted $0.85 EPS. Clorox’s revenue was up 33.3% on a year-over-year basis.
Clorox Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 4.5%. The ex-dividend date of this dividend was Wednesday, October 28th. Clorox’s dividend payout ratio (DPR) is 89.93%.
Insider Transactions at Clorox
In related news, Director Pierre Breber purchased 4,000 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were acquired at an average cost of $100.06 per share, for a total transaction of $400,240.00. Following the acquisition, the director owned 22,000 shares of the company’s stock, valued at $2,201,320. The trade was a 22.22% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.51% of the company’s stock.
Institutional Investors Weigh In On Clorox
Hedge funds have recently made changes to their positions in the stock. Empirical Finance LLC boosted its position in Clorox by 0.9% during the third quarter. Empirical Finance LLC now owns 11,313 shares of the company’s stock valued at $916,000 after purchasing an additional 96 shares in the last quarter. Geneos Wealth Management Inc. grew its stake in Clorox by 9.3% in the first quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company’s stock valued at $145,000 after purchasing an additional 119 shares during the last quarter. Elevation Wealth Partners LLC raised its holdings in Clorox by 32.3% in the third quarter. Elevation Wealth Partners LLC now owns 565 shares of the company’s stock worth $46,000 after purchasing an additional 138 shares in the last quarter. Eastern Bank raised its holdings in Clorox by 3.1% in the third quarter. Eastern Bank now owns 5,052 shares of the company’s stock worth $409,000 after purchasing an additional 150 shares in the last quarter. Finally, Mystic Asset Management Inc. lifted its position in shares of Clorox by 1.3% during the third quarter. Mystic Asset Management Inc. now owns 12,112 shares of the company’s stock valued at $981,000 after buying an additional 153 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
About Clorox
The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.
Read More
- Five stocks we like better than Clorox
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
